Associations between body mass index and the risk of renal events in patients with type 2 diabetes

Associations between body mass index and the risk of renal events in patients with type 2 diabetes

<p>Background/Objectives: We aimed to evaluate the relationship between BMI and the risk of renal disease in patients with type 2 diabetes in the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation (ADVANCE) study.</p><p> Subjects/...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Mohammedi, K, Chalmers, J, Herrington, W, Li, Q, Mancia, G, Marre, M, Poulter, N, Rodgers, A, Williams, B, Perkovic, V, Coresh, J, Woodward, M
Fformat:	Journal article
Cyhoeddwyd:	Nature Publishing Group 2018

Eitemau Tebyg

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
gan: Kamel Mohammedi, et al.
Cyhoeddwyd: (2021-01-01)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
gan: Mohammedi, K, et al.
Cyhoeddwyd: (2017)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: results from ADVANCE-ON
gan: Jun, M, et al.
Cyhoeddwyd: (2017)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON.
gan: Jun, M, et al.
Cyhoeddwyd: (2017)

Lowering blood pressure reduces renal events in type 2 diabetes.
gan: de Galan, B, et al.
Cyhoeddwyd: (2009)

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
gan: Ohkuma, T, et al.
Cyhoeddwyd: (2019)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
gan: Woodward, M, et al.
Cyhoeddwyd: (2016)

Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England
gan: Herrington, W, et al.
Cyhoeddwyd: (2017)

Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
gan: Atkins, A, et al.
Cyhoeddwyd: (2017)

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study
gan: Blomster, J, et al.
Cyhoeddwyd: (2017)

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
gan: Ohkuma, T, et al.
Cyhoeddwyd: (2018)

Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes
gan: Mohammedi, K, et al.
Cyhoeddwyd: (2016)

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
gan: Ohkuma, T, et al.
Cyhoeddwyd: (2017)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
gan: Perkovic, V, et al.
Cyhoeddwyd: (2013)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
gan: Mohammedi, K, et al.
Cyhoeddwyd: (2016)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
gan: van Steen, S, et al.
Cyhoeddwyd: (2018)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
gan: Woodward, M, et al.
Cyhoeddwyd: (2016)

The relationship between plasma 8-OH-deoxyguanosine and cardiovascular disease and survival in type 2 diabetes: results from the ADVANCE study
gan: Thomas, M, et al.
Cyhoeddwyd: (2018)

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
gan: Rahman, F, et al.
Cyhoeddwyd: (2019)

The influence of sex on the prognostic value of body mass index in non-metastasis renal cell carcinoma
gan: Zheng Y, et al.
Cyhoeddwyd: (2019-05-01)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
gan: Lv, J, et al.
Cyhoeddwyd: (2012)

Impact of Body Mass Index on Survival of Metastatic Renal Cancer
gan: Jose Javier Salgado, et al.
Cyhoeddwyd: (2021-07-01)

Association of Body Mass Index and Food Intake with Renal Cell Carcinoma
gan: Negin Basiri, et al.
Cyhoeddwyd: (2015-02-01)

CORRELATION BETWEEN ACUTE CORONARY EVENTS AND BODY MASS INDEX VALUES
gan: Maria Marilena Frunzulică, et al.
Cyhoeddwyd: (2019-09-01)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
gan: Patel, A, et al.
Cyhoeddwyd: (2007)

Severe Hypoglycemia and Risks of Vascular Events and Death
gan: Zoungas, S, et al.
Cyhoeddwyd: (2010)

Visceral Adiposity Index, Body Fat Index and Fat Mass In Patients with Chronic Renal Failure
gan: Sema Kunt, et al.
Cyhoeddwyd: (2020-06-01)

Plasma lipidomic profiles improve upon traditional risk factors for the prediction of cardiovascular events in type 2 diabetes
gan: Alshehry, Z, et al.
Cyhoeddwyd: (2016)

Strategies to meet the need for long-term data
gan: Chalmers, J, et al.
Cyhoeddwyd: (2016)

Body mass index and comorbidity are associated with postoperative renal function after nephrectomy
gan: Lael Reinstatler, et al.
Cyhoeddwyd: (2015-08-01)

Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer
gan: Alexander Hintze Hillers, et al.
Cyhoeddwyd: (2024-08-01)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
gan: Zoungas, S, et al.
Cyhoeddwyd: (2009)

Appearance Comparison, Body Appreciation, and Adolescent Depressive Symptoms: Roles of Gender, Age, and Body-Mass Index
gan: Zheng Q, et al.
Cyhoeddwyd: (2024-10-01)

Body mass index and age as determinants of renal hemodynamics and reserve capacity after living kidney donation
gan: Rook, M, et al.
Cyhoeddwyd: (2006)

Pooled RCTs: Atorvastatin did not increase renal-related serious adverse events
gan: Herrington, W, et al.
Cyhoeddwyd: (2014)

Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCE
gan: Shoujiang You, et al.
Cyhoeddwyd: (2025-02-01)

Sex-specific body mass index to optimize low correlation with height and high correlation with fatness: a UK Biobank study
gan: Feng, Q, et al.
Cyhoeddwyd: (2023)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
gan: Hua, X, et al.
Cyhoeddwyd: (2020)

Effect of body mass index on serum urate and renal uric acid handling responses to an oral inosine load: experimental intervention study in healthy volunteers
gan: Nicola Dalbeth, et al.
Cyhoeddwyd: (2020-11-01)

Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
gan: Iurilli, MLC, et al.
Cyhoeddwyd: (2021)